| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 13598 | 2018 |
| Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The lancet 390 (10113), 2627-2642, 2017 | 7763 | 2017 |
| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... European heart journal 42 (14), 1289-1367, 2021 | 5079 | 2021 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 1911 | 2021 |
| Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1035 | 2013 |
| Facilitated PCI in patients with ST-elevation myocardial infarction SG Ellis, M Tendera, MA de Belder, AJ van Boven, P Widimsky, ... New England Journal of Medicine 358 (21), 2205-2217, 2008 | 876 | 2008 |
| 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by … G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ... Journal of hypertension 41 (12), 1874-2071, 2023 | 639* | 2023 |
| Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ... The Lancet 396 (10266), 1895-1904, 2020 | 560 | 2020 |
| Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ... Journal of the American College of Cardiology 61 (2), 196-206, 2013 | 495 | 2013 |
| The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1· 1 million adults P Geldsetzer, J Manne-Goehler, ME Marcus, C Ebert, Z Zhumadilov, ... The Lancet 394 (10199), 652-662, 2019 | 483 | 2019 |
| May Measurement Month 2017: an analysis of blood pressure screening results worldwide T Beaney, AE Schutte, M Tomaszewski, C Ariti, LM Burrell, RR Castillo, ... The Lancet Global Health 6 (7), e736-e743, 2018 | 357 | 2018 |
| Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based … A Rodriguez-Martinez, B Zhou, MK Sophiea, J Bentham, CJ Paciorek, ... The Lancet 396 (10261), 1511-1524, 2020 | 346 | 2020 |
| Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation V Vaccarino, L Badimon, JD Bremner, E Cenko, J Cubedo, M Dorobantu, ... European heart journal 41 (17), 1687-1696, 2020 | 340* | 2020 |
| Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and … V Vaccarino, L Badimon, R Corti, C De Wit, M Dorobantu, A Hall, A Koller, ... Cardiovascular research 90 (1), 9-17, 2011 | 325 | 2011 |
| May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension T Beaney, LM Burrell, RR Castillo, FJ Charchar, S Cro, A Damasceno, ... European heart journal 40 (25), 2006-2017, 2019 | 254 | 2019 |
| Health system performance for people with diabetes in 28 low-and middle-income countries: a cross-sectional study of nationally representative surveys J Manne-Goehler, P Geldsetzer, K Agoudavi, G Andall-Brereton, KK Aryal, ... PLoS medicine 16 (3), e1002751, 2019 | 251 | 2019 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and … AR Pries, L Badimon, R Bugiardini, PG Camici, M Dorobantu, DJ Duncker, ... European heart journal 36 (45), 3134-3146, 2015 | 235 | 2015 |
| Effects of serelaxin in patients with acute heart failure M Metra, JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... New England Journal of Medicine 381 (8), 716-726, 2019 | 217 | 2019 |
| ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... Eur Heart J 42 (14), 1289-1367, 2021 | 208 | 2021 |
